METIS TECHBIO-P (07666.HK): plans H-share buyback of up to HKD 300m

On 20 November 2026, METIS TECHBIO-P (07666.HK) planned an on-market H-share buyback of up to HKD 300 million under a general mandate, using internal funds.
Key Highlights:
  • The buyback cap is HKD 300 million, to be executed on market from time to time under the 22 April 2026 general mandate.
  • Funding comes from internal or self-raised resources, excluding global offering proceeds.

NewTimeSpace News: On 20 November 2026, Metis TechBio Co., Ltd. (stock code: 07666) said it may buy back H shares on the open market from time to time, for a total of up to HKD 300 million, under the general mandate approved by shareholders at the annual general meeting on 22 April 2026.

The buyback will be funded from internal resources or other self-raised funds lawfully available for the purpose, excluding proceeds from the global offering. The buyback period runs from the announcement date until the earlier of the conclusion of the next annual general meeting or the revocation or variation of the mandate by special resolution. No H shares have been repurchased so far. Repurchased shares will be cancelled or held in treasury as the Board considers appropriate, and the Company does not expect the public float to fall below the minimum percentage required. The buyback depends on market conditions and is at the Board's discretion, with no assurance on timing, volume or price.

×
Share to WeChat

Open WeChat, use the "Scan", and share to my Moments.